Greer Appoints Terrance C. Coyne, M.D. as Chief Medical Officer and Expands Clinical and Medical Affairs Programs

Greer Appoints Terrance C. Coyne, M.D. as Chief Medical Officer and Expands Clinical and Medical Affairs Programs

LENOIR, N.C.--(EON: Enhanced Online News)--Greer, a leading developer and provider of allergy immunotherapy products, announced today the appointment of Terrance C. Coyne, M.D. as chief medical officer. In this important role, Coyne will lead and oversee the planned expansion of Greer's medical and clinical affairs programs. The structure change is designed to bridge Greer's existing Research & Development and clinical affairs initiatives into a comprehensive, customer-centered medical and clinical affairs division to provide increased value and service to the medical community as well as the public.

"As Greer continues to grow, this strategic structure is needed and we see it as part of our ongoing commitment to the allergy specialty. We are growing our company to better serve and provide the specialized services our customers need."
"We are excited to have Dr. Coyne join Greer in this leadership position," says John G. Roby, president and CEO of Greer. "As Greer continues to grow, this strategic structure is needed and we see it as part of our ongoing commitment to the allergy specialty. We are growing our company to better serve and provide the specialized services our customers need."

Coyne brings more than 20 years of medical affairs experience in the global pharmaceutical and biotechnology sectors. He has been directly involved in all functions including preclinical, launch and post commercialization, R&D, clinical development and has served as product development leader with numerous New Drug Applications (NDAs) and their global equivalents. His experience spans multiple therapeutic categories including allergy, respiratory, anti-inflammatory and vaccines as well as drug technology. Prior to joining Greer, Coyne served as chief medical officer at Ventrus Biosciences, Encysive Pharmaceuticals and Metaphore Pharmaceuticals.

About Greer

Greer is a leading developer and provider of allergy immunotherapy products and services for treating humans and animals. Greer's scientists provide technical support for customers by continuing to focus on improving the lives of allergic patients. The company was founded in 1904 and is located in Lenoir, N.C. For more information, visit www.greerlabs.com.


Contacts
For Greer
Andrea Moody, 919-457-0743
[email protected]

Suggested Articles

I-MAB's anti-GM-CSF drug works "upstream" in inflammation pathways, potentially blocking several dangerous cytokines in COVID-19, executives…

Antibe's lead drug beat placebo at reducing osteoarthritis pain, boosting its case as an alternative to NSAIDs, commonly used to treat the condition.

The trial marks the start of a new phase of the response to SARS-CoV-2 in which people will receive drugs designed specifically for the virus.